How to appeal a Cigna diabetes drugs & insulin denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Cigna-specific note: Sold its Medicaid Advantage book to HCSC in 2023. Express Scripts (PBM) is Cigna-owned. Frequent class-action litigation around mental health parity.

What Cigna's policy requires for diabetes drugs & insulin

Cited policy: Cigna / Express Scripts GLP-1 RA Prior Authorization — Type 2 Diabetes

Confirmed T2D (ICD E11.x), A1c ≥6.5% or on antihyperglycemic therapy, trial of metformin ≥90 days unless contraindicated. Documentation it is NOT being used for weight loss alone.

How Cigna denies diabetes drugs & insulin — and how to counter it

Where Cigna pushes back: 1) No metformin trial; 2) Suspected weight-loss use; 3) Try Trulicity before Mounjaro.

Counter-arguments that hold up: Document metformin titration / intolerance. SURPASS-2 NEJM 2021 superiority of tirzepatide vs semaglutide. ADA 2025 §9.4 GLP-1/GIP early use with ASCVD/HF/CKD. Mounjaro FDA-approved May 13, 2022 for T2D — distinct indication from Zepbound.

What Cigna typically denies for diabetes drugs & insulin

Across Cigna's commercial and Medicare books, denials cluster around a small number of patterns. For diabetes drugs & insulin, expect:

• Mental health parity violations
• Step therapy
• Specialty drug prior auth
• OON balance billing disputes

Treatments most often denied in this category

These are the diabetes drugs & insulin treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Rapid-acting analog insulin
• Basal analog insulin
• Pre-mixed insulin
• Concentrated insulin
• GLP-1 for T2D
• DPP-4 inhibitor

How to submit the appeal to Cigna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Cigna cited in the denial.
3. File the appeal through Cigna's portal (members: https://my.cigna.com ; providers: https://cignaforhcp.cigna.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Cigna's prior-authorization criteria by drug: Cigna PA criteria on ApprovalHelp.